CentreStone Ventures

CentreStone Ventures is a venture capital fund based in Winnipeg, Canada, specializing in the life sciences sector. Established in 2004, the firm primarily invests in early-stage companies focused on developing therapeutics, medical devices, diagnostics, and innovative drug delivery methods. Through its investments, CentreStone Ventures aims to support advancements in healthcare and contribute to the growth of emerging companies in the life sciences field.

Albert David Friesen

General Partner and CEO

2 past transactions

Orasi Medical, Inc.

Series B in 2009
Orasi Medical is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. Initially, the company's aim was to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. They have since expanded their efforts towards developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases such as multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD).

Orasi Medical, Inc.

Series A in 2007
Orasi Medical is a privately held, early stage medical device company engaged in the development and commercialization of technology to diagnose and monitor neurological diseases. Initially, the company's aim was to develop the first FDA cleared test for the diagnosis of Alzheimer's disease. They have since expanded their efforts towards developing products for pharmaceutical companies to measure treatment effect and reduce the cost of clinical drug trials for neurological diseases such as multiple sclerosis, Parkinson's, autism, depression and attention deficit hyperactivity disorder (ADHD).